<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
BIOFILCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biofil Chemicals & Pharmaceuticals has submitted a filing to BSE confirming it does NOT qualify as a 'Large Corporate' under SEBI's framework as on 31st March 2025. The company reported zero outstanding borrowings (Rs. 0.00 crore) and has not obtained any credit rating. This is a routine annual compliance disclosure required under SEBI's operational circular dated August 10, 2021, which applies to large entities raising funds through debt securities. Since the company falls outside the large corporate criteria, it is exempt from the additional borrowing and disclosure obligations applicable to large corporates.
This is a standard regulatory compliance filing with no material impact on shareholders. The zero-debt position is mildly reassuring but does not change the investment thesis for the stock.